Literature DB >> 20924732

Acute renal failure associated with systemic polyoma BK virus activation in a patient with peripheral T-cell lymphoma.

Kazunari Aoki1, Shinichi Kotani, Tatsuo Ichinohe, Tadakazu Kondo, Takayuki Ishikawa.   

Abstract

Renal dysfunction associated with polyoma BK virus (BKV) reactivation usually occurs in the setting of profound immunosuppression related to renal transplantation and hematopoietic stem cell transplantation. However, it has been rarely described as a complication during the course of conventional chemotherapy. Here, we report a case of BKV-associated acute renal failure developed in a patient suffering from refractory peripheral T-cell lymphoma, not otherwise specified. After repetitive cycles of salvage chemotherapy, the patient developed fever and urinary frequency, rapidly followed by anuria that necessitated the emergent institution of hemodialysis. Cytologic examination of the urine revealed the presence of decoy cells and positive immunostaining for polyomavirus simian virus 40 antigen. High levels of BKV were detected in urine and plasma with quantitative real-time polymerase chain reaction, strongly suggesting that his renal failure was due to polyoma virus-associated nephropathy. This rare complication should be kept in mind in case of unexplained renal failure developed in immunodeficient patients undergoing cytotoxic chemotherapy.

Entities:  

Mesh:

Year:  2010        PMID: 20924732     DOI: 10.1007/s12185-010-0694-6

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  16 in total

1.  Gemcitabine, dexamethasone and cisplatin is an active and non-toxic chemotherapy regimen in relapsed or refractory Hodgkin's disease: a phase II study by the National Cancer Institute of Canada Clinical Trials Group.

Authors:  T Baetz; A Belch; S Couban; K Imrie; J Yau; R Myers; K Ding; N Paul; L Shepherd; J Iglesias; R Meyer; M Crump
Journal:  Ann Oncol       Date:  2003-12       Impact factor: 32.976

2.  EPOCH chemotherapy: toxicity and efficacy in relapsed and refractory non-Hodgkin's lymphoma.

Authors:  W H Wilson; G Bryant; S Bates; A Fojo; R E Wittes; S M Steinberg; D R Kohler; E S Jaffe; J Herdt; B D Cheson
Journal:  J Clin Oncol       Date:  1993-08       Impact factor: 44.544

3.  Treatment of renal allograft polyoma BK virus infection with leflunomide.

Authors:  Michelle A Josephson; Daniel Gillen; Basit Javaid; Pradeep Kadambi; Shane Meehan; Preston Foster; Robert Harland; Richard J Thistlethwaite; Marc Garfinkel; Walter Atwood; Joslynn Jordan; Molly Sadhu; Michael J Millis; James Williams
Journal:  Transplantation       Date:  2006-03-15       Impact factor: 4.939

4.  The role of BK virus in acute respiratory tract disease and the presence of BKV DNA in tonsils.

Authors:  J Goudsmit; P Wertheim-van Dillen; A van Strien; J van der Noordaa
Journal:  J Med Virol       Date:  1982       Impact factor: 2.327

5.  Quantitative viral load monitoring and cidofovir therapy for the management of BK virus-associated nephropathy in children and adults.

Authors:  Abhay Vats; Ron Shapiro; Parmjeet Singh Randhawa; Velma Scantlebury; Acar Tuzuner; Malika Saxena; Michael L Moritz; T James Beattie; Thomas Gonwa; Michael D Green; Demetrius Ellis
Journal:  Transplantation       Date:  2003-01-15       Impact factor: 4.939

Review 6.  BK virus nephropathy after allogeneic stem cell transplantation: a case report and literature review.

Authors:  Lazaros J Lekakis; Valentina Macrinici; Ioannis G Baraboutis; Bonnie Mitchell; Dianna S Howard
Journal:  Am J Hematol       Date:  2009-04       Impact factor: 10.047

7.  Polyomavirus polymerase chain reaction as a surrogate marker of polyomavirus-associated nephropathy.

Authors:  Helen B Viscount; Albert J Eid; Mark J Espy; Matthew D Griffin; Kristine M Thomsen; William S Harmsen; Raymund R Razonable; Thomas F Smith
Journal:  Transplantation       Date:  2007-08-15       Impact factor: 4.939

8.  BK virus nephropathy in an immunodeficient patient with chronic lymphocytic leukemia.

Authors:  Akke van der Bij; Michiel Betjes; Jan Weening; Jan Cornelissen; Ted Mes; Albertus Osterhaus; Matthias Beersma
Journal:  J Clin Virol       Date:  2009-05-27       Impact factor: 3.168

9.  [Salvage chemotherapy for relapsed/refractory aggressive non-Hodgkin's lymphoma with a combination of dexamethasone, etoposide, ifosfamide and carboplatin].

Authors:  M Okamoto; F Maruyama; M Tsuzuki; T Nomura; H Miyazaki; M Wakita; H Kojima; R Sobue; T Matsui; T Ino
Journal:  Rinsho Ketsueki       Date:  1994-07

Review 10.  Polyomavirus BK.

Authors:  Hans H Hirsch; Jürg Steiger
Journal:  Lancet Infect Dis       Date:  2003-10       Impact factor: 25.071

View more
  1 in total

Review 1.  BK nephropathy in the native kidneys of patients with organ transplants: Clinical spectrum of BK infection.

Authors:  Darlene Vigil; Nikifor K Konstantinov; Marc Barry; Antonia M Harford; Karen S Servilla; Young Ho Kim; Yijuan Sun; Kavitha Ganta; Antonios H Tzamaloukas
Journal:  World J Transplant       Date:  2016-09-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.